Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1
article
OA: closed
CC0
⤵ 230 in-corpus citations
AI-generated summary
Aromatase cytochrome P450 protein and mRNA were found in human endometriotic and adenomyotic tissues, indicating local estrogen production, but were absent in normal endometrium.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
To determine whether local estrogen production takes place in endometriotic or adenomyotic tissues, in eutopic endometrium from patients with endometriosis or adenomyosis, and in normal endometrium, tissue specimens were examined by immunohistochemistry, catalytic activity, and mRNA expression for aromatase cytochrome P450 (P450arom). P450arom was immunohistochemically localized in the cytoplasm of glandular cells of endometriotic and adenomyotic tissues, and of eutopic endometrium from patients with the respective diseases, whereas estrogen receptors and progesterone receptors were localized in the nuclei of the glandular cells and stroma. Aromatase activity in the microsomal fraction of adenomyotic tissues was inhibited by the addition of danazol, aromatase inhibitors, and anti-human placental P450arom monoclonal antibody (mAb3-2C2) in a manner similar to such inhibition in other human tissues. Reverse transcription polymerase chain reaction and Southern blot analysis also revealed P450arom mRNA in these tissues. However, neither P450arom protein activity nor mRNA was detected in endometrial specimens obtained from normal menstruating women with cervical carcinoma in situ but without any other gynecological disease. These results suggest that at a local level, endometriotic and adenomyotic tissues produce estrogens, which may be involved in the tissue growth through interacting with the estrogen receptor.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (45)
- Aromatase expression in endometriosis via openalex
- Aromatase expression in endometriosis. via openalex
- Danazol Binding to Rat Androgen, Glucocorticoid, Progesterone, and Estrogen Receptors: Correlation With Biologic Activity via openalex
- Endometriosis : current understanding and management via openalex
- Endometriosis: Immunohistochemical analysis of oestrogen and progesterone receptors in endometriotic tissue and endometrium via openalex
- Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue via openalex
- Estrogen biosynthesis in human uterine adenomyosis via openalex
- Evidence for estrogen synthesis in adenomyotic tissues via openalex
- Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy via openalex
- The inductive effects of progestogens on aromatase activity in stromal cells of human uterine endometrium via openalex
- The peritoneal environment in endometriosis via openalex
- W2015854414 via openalex
- W2019344546 via openalex
- W2037988184 via openalex
- W2042411692 via openalex
- W2058024995 via openalex
- W2066084415 via openalex
- W2069877703 via openalex
- W2071612794 via openalex
- W2072181546 via openalex
- W2087847123 via openalex
- W2098450800 via openalex
- W2117303589 via openalex
- W2148885338 via openalex
- W2149383746 via openalex
- W2163168485 via openalex
- W2223229280 via openalex
- W2310275009 via openalex
- W2408940431 via openalex
- W2411301886 via openalex
- W4243625730 via openalex
- W4247670289 via openalex
- W4251631615 via openalex
- W4253097306 via openalex
- W4234889952 via openalex
- W1964766585 via openalex
- W1965188700 via openalex
- W1967829480 via openalex
- W1974730779 via openalex
- W1987901317 via openalex
- W1996354403 via openalex
- W2001810436 via openalex
- W2001831389 via openalex
- W2008492770 via openalex
- W2009307286 via openalex
Cited by (50)
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- Advances in Metabolic Syndrome and Endometriosis: Emerging Insights and Therapeutic Horizons 2026
- Molecular Basis of Impaired Decidualization in the Eutopic Endometrium of Endometriosis Patients 2025
- Decreased Glycolysis Due to Lactate Dehydrogenase A N6-Methyladenosine Methylation in Endometrium of Endometriosis Impairs Its Decidualization and Contributes to Related Infertility 2025
- Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium 2025
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- The effect of androgens on the risk of endometriosis sub-phenotypes and ovarian neoplasms: A Mendelian randomization study 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- [Research Progress in the Role of Mitochondrial Dysfunction in Endometriosis-Associated Infertility] 2024
- Adenomyosis, especially in its focal nature, hampers implantation and live birth rate after single euploid embryo transfer 2024
- Using a Quantitative High-Throughput Screening Platform to Identify Molecular Targets and Compounds as Repurposing Candidates for Endometriosis 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- ENDOMETRIOZLARNI IMMUNOGISTOKIMYOVIY O’ZGARISHLARI TAVSIFI 2023
- Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial 2023
- Evaluation of aromatase expression in endometrioid heterotopias and endometria in patients with external genital endometriosis 2023
- Research progress on the understanding and treatment of endometriosis in traditional Chinese and western medicine 2023
- Evaluation Of Mammographic Features In Women With Adenomyosis 2022
- Adenomyosis in Reproductive Years: Fertility and ART in Adenomyosis 2022
- Endometriosis and adenomyosis: common and disparate features 2022
- Mechanisms and Pathogenesis of Adenomyosis 2022
- Endometriosis biomarkers of the disease: an update 2022
- Insights on Adenomyosis Development 2022
- The Menstrual Endometrium: From Physiology to Future Treatments 2022
- The gut microbiota: a double-edged sword in endometriosis† 2022
- Endometriosis Research: From Bench to Bedside 2022
- Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy 2022
- Evaluation of mammographic features in women with adenomyosis 2022
- Diagnosis and Surgical Management of Adenomyosis 2022
- Adenomyosis decreases the live birth rate but may not affect perinatal outcomes in assisted reproductive cycles 2022
- Overexpression of Human Estrogen Biosynthetic Enzyme Hydroxysteroid (17beta) Dehydrogenase Type 1 Induces Adenomyosis-like Phenotype in Transgenic Mice 2022
- Low-Nutrient Environment-Induced Changes in Inflammation, Cell Proliferation, and PGC-1α Expression in Stromal Cells with Ovarian Endometriosis 2022
- Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Danazol, Aromatase Inhibitors 2022
- Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists 2021
- Maternal–Fetal Outcomes in Women with Endometriosis and Shared Pathogenic Mechanisms 2021
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Physiopathologie de l’adénomyose : une énigme non résolue 2021
- Narrative review of hysteroscopy and endometriosis treatment 2021
- Immunological changes associated with adenomyosis: a systematic review 2020
- Should the patients with endometriosis be treated as a risk group of pregnancy complications? Single center experience and literature review and literature review 2020
- The Pathogenesis of Adenomyosis vis-à-vis Endometriosis 2020
- The clinicopathological characteristics and survival outcomes of endometrial carcinoma coexisting with or arising in adenomyosis: A pilot study 2020
- Celecoxib, a selective COX‑2 inhibitor, markedly reduced the severity of tamoxifen‑induced adenomyosis in a murine model 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Current and Future Medical Therapies for Adenomyosis 2020
- Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis 2020
- Lipoxin A4 inhibits the development of endometriosis in a mouse model by suppressing local estradiol synthesis 2020
- Current theories on endometriosis pathogenesis 2020
- An Update on the Various Theories of the Origin of Uterine Adenomyosis –A Systematic Review 2020
- The association between adenomyosis and recurrent miscarriage 2020
Source provenance
- europepmc
- last seen: 2026-06-17T06:13:18.893374+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:10:46.468712+00:00
License: CC0
· commercial use OK